ArticleMolecular therapy. Methods & clinical development2022

Preclinical assessment of an optimized AAV-FVIII vector in mice and non-human primates for the treatment of hemophilia A.

Liron Elkouby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.